Patent ID: 9040022
Filing Date: 2015-05-26
Classification: A61K,A61P,B82Y

Abstract:
1. A substantially spherical microsphere comprising: a biocompatible polymeric material comprising polyvinylalcohol, doxorubicin in a concentration of about 10 mg to about 400 mg of doxorubicin per 100 mg of dry microspheres, and a non-ionic contrast agent containing iodine, wherein the concentration of the non-ionic contrast agent is from about 100 mg to about 3200 mg iodine per 100 mg of dry microspheres, wherein the microsphere is swellable in a pharmaceutically acceptable solution and has a diameter of from about 10 μm to about 1000 μm before swelling, and wherein the diameter of the microsphere is from about 40 μm to about 2000 μm after swelling.